Heather C. Getz - 14 Aug 2026 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: TELA
Reported as of: 14 Aug 2026
Net transaction value: +$10,467
SEC form: 4
Accepted by SEC: 17 Aug 2026, 16:32:41 UTC
Prior SEC filing: 05 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Megan Smeykal, Attorney-in-Fact

Key filing fact

Heather C. Getz filed Form 4 for TELA Bio, Inc. (TELA) on 17 Aug 2026.

Key facts

This page summarizes Heather C. Getz's Form 4 filing for TELA Bio, Inc. (TELA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2026, 16:32.

Change

Previous filing in this sequence was filed on 05 Aug 2026.
Current net transaction value: +$10,467.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001481485 Primary reporting owner

Getz Heather C

Relationship: Chief Executive Officer, Director
Address: C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN
Signature: /s/ Megan Smeykal, Attorney-in-Fact
Signature date: 17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TELA transaction

Common Stock

Purchase

Transaction value: $10,467
Shares: +15,000
Change %: +3%
Price: $0.6978
Shares after: 520,000
Date: 14 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.697 to $0.6994. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.